| Changes in coping, pain, and activity after cognitive-behavioral training: a randomized clinical trial for pediatric sickle cell disease using smartphones J Schatz, AM Schlenz, CB McClellan, ES Puffer, S Hardy, M Pfeiffer, ... The Clinical journal of pain 31 (6), 536-547, 2015 | 86 | 2015 |
| Age differences in emergency department visits and inpatient hospitalizations in preadolescent and adolescent youth with autism spectrum disorders AM Schlenz, LA Carpenter, C Bradley, J Charles, A Boan Journal of Autism and Developmental Disorders 45, 2382-2391, 2015 | 36 | 2015 |
| Examining biopsychosocial factors in relation to multiple pain features in pediatric sickle cell disease AM Schlenz, J Schatz, CW Roberts Journal of pediatric psychology 41 (8), 930-940, 2016 | 33 | 2016 |
| Responsiveness of the PedsQL to pain-related changes in health-related quality of life in pediatric sickle cell disease AM Schlenz, J Schatz, CB McClellan, CW Roberts Journal of Pediatric Psychology 37 (7), 798-807, 2012 | 32 | 2012 |
| Transcranial doppler screening in a current cohort of children with sickle cell anemia: results from the DISPLACE study J Kanter, S Phillips, AM Schlenz, M Mueller, M Dooley, L Sirline, R Nickel, ... Journal of pediatric hematology/oncology 43 (8), e1062-e1068, 2021 | 25 | 2021 |
| Sensitization to acute procedural pain in pediatric sickle cell disease: modulation by painful vaso-occlusive episodes, age, and endothelin-1 AM Schlenz, CB McClellan, TRM Mark, AD McKelvy, E Puffer, ... The Journal of Pain 13 (7), 656-665, 2012 | 22 | 2012 |
| Modulation of pain in pediatric sickle cell disease: understanding the balance between endothelin mediated vasoconstriction and apelin mediated vasodilation TP Smith, AM Schlenz, JC Schatz, R Maitra, SM Sweitzer Blood Cells, Molecules, and Diseases 54 (2), 155-159, 2015 | 19 | 2015 |
| Predictive validity of developmental screening in young children with sickle cell disease: A longitudinal follow‐up study J Schatz, AM Schlenz, KE Smith, CW Roberts Developmental Medicine & Child Neurology 60 (5), 520-526, 2018 | 17 | 2018 |
| Needs assessment for patients with sickle cell disease in South Carolina, 2012 AM Schlenz, AD Boan, DT Lackland, RJ Adams, J Kanter Public Health Reports 131 (1), 108-116, 2016 | 15 | 2016 |
| Developmental screening in pediatric sickle cell disease: Disease-related risk and screening outcomes in 4 year olds J Schatz, A Schlenz, L Reinman, K Smith, CW Roberts Journal of Developmental & Behavioral Pediatrics 38 (8), 654-662, 2017 | 13 | 2017 |
| Health-related quality of life in children with sickle cell disease undergoing chronic red cell transfusion therapy SL Maxwell, AM Schlenz, J Kanter Journal of Pediatric Hematology/Oncology 41 (4), 307-312, 2019 | 12 | 2019 |
| Changes in care delivery for children with sickle cell anemia during the COVID-19 pandemic ML Noisette, S Phillips, AM Schlenz, M Mueller, J Kanter Journal of pediatric hematology/oncology 43 (8), e1231-e1234, 2021 | 11 | 2021 |
| Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium AM Schlenz, S Phillips, M Mueller, C Melvin, RJ Adams, J Kanter, ... Pediatric blood & cancer 67 (4), e28172, 2020 | 6 | 2020 |
| Information-Seeking Coping Behaviors During Painful Procedures in African-American Children with Sickle Cell Disease AM Schlenz, J Schatz, CB McClellan, SM Sweitzer, CW Roberts Pain Management Nursing 14 (3), e54-e58, 2013 | 5 | 2013 |
| Identified barriers and facilitators to stroke risk screening in children with sickle cell anemia: results from the DISPLACE consortium SM Phillips, AM Schlenz, M Mueller, CL Melvin, RJ Adams, J Kanter Implementation Science Communications 2 (1), 87, 2021 | 4 | 2021 |
| Barriers and facilitators to chronic red cell transfusion therapy in pediatric sickle cell anemia AM Schlenz, SM Phillips, M Mueller, CL Melvin, RJ Adams, J Kanter Journal of Pediatric Hematology/Oncology Nursing 39 (4), 209-220, 2022 | 3 | 2022 |
| Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium S Phillips, AM Schlenz, M Mueller, C Melvin, RJ Adams, J Kanter, ... Pediatric blood & cancer 67 (11), e28569, 2020 | 3 | 2020 |
| Patient and family opioid decision-making for pain management in sickle cell disease: A qualitative study S Phillips, AM Schlenz, S D'Alton, M Johnson, J Kanter The Journal of Pain 24 (7), 1240-1250, 2023 | 2 | 2023 |
| Sleep quality and pain in adolescents and young adults with sickle cell disease AM Schlenz, SJ Thomas, G Gloston, J Lebensburger, SL Maxwell, ... Journal of Clinical Sleep Medicine 18 (12), 2845-2853, 2022 | 2 | 2022 |
| Moyamoya disease predicts progression of cerebral vasculopathy in patients with sickle cell disease despite chronic transfusion therapy AM Schlenz, MU Antonucci, R Cafiero, NS Burkett, J Kanter Blood 126 (23), 2071, 2015 | 2 | 2015 |
Eve PufferDuke UniversityVerified email at duke.edu
